Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from MedAdvisor Limited ( (AU:AHE) ).
Adheris Health has updated its Securities Trading Policy in line with ASX requirements, releasing a revised framework that governs how its officers and employees can trade in the company’s securities. The board has resolved to replace the prior model of designated trading windows with closed periods, tightening governance around when insiders may deal in shares.
The move underscores a stronger emphasis on compliance and market integrity as the company scales its pharmacy engagement platform in the U.S. market. By formalising closed periods, Adheris Health aims to reduce the risk of perceived or actual insider trading, which may support investor confidence and align the company with prevailing corporate governance best practices on the ASX.
The most recent analyst rating on (AU:AHE) stock is a Hold with a A$0.10 price target. To see the full list of analyst forecasts on MedAdvisor Limited stock, see the AU:AHE Stock Forecast page.
More about MedAdvisor Limited
Adheris Health Limited is an Australian-listed provider of pharmacy-driven patient engagement solutions focused on personalising the medication journey. Leveraging its cloud-based, AI-enabled THRiV platform, the company enhances pharmacy workflows and patient engagement, working with more than 25,000 pharmacies across the U.S. and reaching over half the population.
Average Trading Volume: 463,626
Technical Sentiment Signal: Sell
Current Market Cap: A$12.12M
See more data about AHE stock on TipRanks’ Stock Analysis page.